Abstract
Peyronie's disease is an inflammatory condition characterized by the formation of fibrous, noncompliant nodules in the tunica albuginea which can impede tunical expansion during penile erection, leading to deformity and bending. While the cause of this disease is thought to be due to microvascular trauma and abnormal wound healing, other hypotheses include genetic predisposition. In this review the pathophysiology of Peyronie's disease is discussed as well as current hypothese regarding its origin.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gelbard M . Peyronie's disease In: Hashmat AI Das S eds The penis. Lea and Febiger: Philadelphia 1993 pp 244–365
Carrier S, Lue TF . For Peyronie's disease, act conservatively Contemporary Urol 1994 9: 54–65
Pryor JP . The management of Peyronie's disease In: Porst H, ed Penile disorders Proceedings of the International Symposium on Penile Disorders, Hamburg, Germany, 26–27 January 1996. Springer Verlag, Berlin 1997 pp 75–86
Devine CJ, Horton CE . Peyronie's disease Clin Plast Surg 1988 15: 405–409
Jarow JP, Lowe FC . Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction J Urol 1997 158: 1388–1390
Devine CJ, Somers KD, Jordan GH, Schlossberg SM . Proposal: trauma as a cause of Peyronie's lesion J Urol 1997 157: 285–290
Vande Berg JS et al. Mechanisms of calcification in Peyronie's disease J Urol 1982 127: 52–54
Krane RJ . The treatment of loss of penile rigidity associated with Peyronie's disease Scand J Urol Nephrol Suppl 1997 179: 147–150
Gasior BL et al. Plaque-associated corporal veno-occlusive dysfunction in idiopathic Peyronie's disease: a pharmacocavernosometric and pharmacocavernosographic study World J Urol 1990 8: 90–97
Lopez JA, Jarow JP . Penile vascular evaluation of men with Peyronie's disease J Urol 1993 149: 53–55
Lyles KW et al. Peyronie's disease is associated with Paget's disease of the bone J Bone Miner Res 1997 12: 929–934
Nyberg LM, Bias WB, Hochberg MC, Walsh PC . Identification of an inherited form of Peyronie's disease with an autosomal dominant inheritance and association with Dupuytren's contracture and histocompatability B7 cross-reactive antigens J Urol 1982 128: 48–52
Ralph DJ et al. The genetic and bacteriological aspects of Peyronie's disease J Urol 1997 157: 291–294
Leffell MS . Is there an immunogenetic basis for Peyronie's disease? J Urol 1997 157: 295–297
Schiavino D et al. Immunologic findings in Peyronie's disease: a controlled study Urology 1997 50: 764–768
Stewart S, Malto M, Sandberg L, Colburn KK . Increased serum levels of anti-elastin antibodies in patients with Peyronie's disease J Urol 1994 152: 105–106
Diegelmann RF . Cellular and biochemical aspects of normal and abnormal wound healing: an overview J Urol 1997 157: 298–302
Lindsay MB et al. The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984 J Urol 1991 146: 1007–1009
Smith BH . Subclinical Peyronie's disease Am J Clin Pathol 1969 52: 385–390
Hsu G-L et al. The three-dimensional structure of the tunica albuginea: anatomical and structural levels Int J Impot Res 1992 4: 117–132
Hsu G-L et al. Anatomy and strength of the tunica albuginea: its relevance to penile prosthesis extrusion J Urol 1994 151: 1205–1208
Brock G et al. The anatomy of the tunica albuginea in the normal penis and in Peyronie's disease J Urol 1997 157: 276–281
Devine CJ . International Conference on Peyronie's Disease: Introduction J Urol 1997 157: 272–275
Gentile V et al. Ultrastructural and immunohistochemical characterization of the tunica albuginea in Peyronie's disease and veno-occlusive function J Androl 1996 17: 96–103
Somers KD et al. Isolation and characterization of collagen in Peyronie's disease J Urol 1989 141: 629–631
Udelson D et al. Engineering analysis of penile hemodynamic and structural dynamic relationships: Part I. Clinical implications of penile tissue mechanical properties Int J Impot Res 1998 10: 15–24
Akkus E et al. Structural alterations in the tunica albuginea of the penis: impact of Peyronie's disease, ageing and impotence Br J Urol 1997 79: 47–53
van de Water L . Mechanisms by which fibrin and fibronectin appear in healing wounds: implications for Peyronie's disease J Urol 1997 157: 306–310
Somers KD, Dawson DM . Fibrin deposition in Peyronie's disease plaque J Urol 1997 157: 311–315
Border WA, Ruoslahti E . Transforming growth factor-β in disease: the dark side of tissue repair J Clin Inv 1992 90: 1–7
Border WA, Noble NA . Transforming growth factor-β in tissue fibrosis N Engl J Med 1994 331: 1286–1291
Moreland RB . Is hypoxemia associated with penile fibrosis? Int J Impot Res 1998 10: 113–120
El-Sakka AI et al. Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression J Urol 1997 158: 1391–1394
El-Sakka AI et al. An animal model of Peyronie's-like condition associated with an increase in transforming growth factor-beta mRNA and protein expression J Urol 1997 158: 2284–2290
El-Sakka AI et al. Histological and ultrastructural alterations in an animal model of Peyronie's disease Br J Urol 1998 81: 445–452
Poli G, Parola M . Oxidative damage and fibrogenesis Free Radical Biol. Med 1997 22: 287–305
Scardino PL, Scott WW . The use of tocopherols in the treatment of Peyronie's disease Ann NY Acad Sci 1949 52: 390–394
Zarafonetis CJD, Horran TM . Treatment of Peyronie's disease with potassium para-aminobenzoate (POTABA) J Urol 1959 81: 770–772
Bartsch G, Menander-Huber KB, Huber W, Marberger H . Orgotein, a new drug for the treatment of Peyronie's disease Eur J Rheumatol Inflamm 1981 4: 250–259
Ludwig G . Evaluation of conservative therapeutic approaches to Peyronie's disease (fibrotic induration of the penis) Urol Int 1991 47: 236–239
Primus G . Orgotein in the treatment of plastic induration of the penis (Peyronie's disease) Int Urol Nephrol 1993 25: 169–172
Lenk S, Schonberger B . Penile deviation-our therapeutic concept Acta Chir Hung 1994 34: 189–194
Flohe L . Superoxide dismutase for therapeutic use: clinical experience, dead ends and hopes Mol Cell Biochem 1988 84: 123–131
Levine LA . Treatment of Peyronie's disease with intralesional verapamil injection J Urol 1997 158: 1395–1399
Rehman J, Benet A, Melman A . Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single blind study Urology 1998 51: 620–626
Akkus E et al. Is colchicine effective in Peyronie's disease? A pilot study Urology 1994 44: 291–295
Gelbard MK, James K, Riach P, Dorey F . Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study J Urol 1993 149: 56–58
Judge JS, Wisniewski ZS . Intralesional interferon in the treatment of Peyronie's disease: a pilot study Br J Urol 1997 79: 40–42
Polat O et al. Peyronie's disease: intralesional treatment with interferon alpha 2-A and evaluation of results by magnetic resonance imaging Int Urol Nephrol 1997 29: 465–471
Ralph DJ, Brooks MD, Botazzo GF, Pryor JP . The treatment of Peyronie's disease with tamoxifen Br J Urol 1992 70: 648–651
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moreland, R., Nehra, A. Pathophysiology of Peyronie's disease. Int J Impot Res 14, 406–410 (2002). https://doi.org/10.1038/sj.ijir.3900875
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3900875
Keywords
This article is cited by
-
Characterization of a novel rabbit model of Peyronie’s disease
International Journal of Impotence Research (2023)
-
Indications and characteristics of penile traction and vacuum erection devices
Nature Reviews Urology (2022)
-
Trends in treatment of Peyronie’s disease in adult men in the United States from 2008 to 2017—results from an encounter and claims database
International Journal of Impotence Research (2022)
-
Intraoperative methods for residual curvature correction during penile prosthesis implantation in patients with Peyronie’s disease and refractory erectile dysfunction
International Journal of Impotence Research (2020)
-
A review of inflammation and fibrosis: implications for the pathogenesis of Peyronie’s disease
World Journal of Urology (2020)